Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team - PubMed (original) (raw)
. 2000 Mar 9;342(10):681-9.
doi: 10.1056/NEJM200003093421002.
Affiliations
- PMID: 10706897
- DOI: 10.1056/NEJM200003093421002
Free article
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team
J P Nuorti et al. N Engl J Med. 2000.
Free article
Abstract
Background: Approximately half of otherwise healthy adults with invasive pneumococcal disease are cigarette smokers. We conducted a population-based case-control study to assess the importance of cigarette smoking and other factors as risk factors for pneumococcal infections.
Methods: We identified immunocompetent patients who were 18 to 64 years old and who had invasive pneumococcal disease (as defined by the isolation of Streptococcus pneumoniae from a normally sterile site) by active surveillance of laboratories in metropolitan Atlanta, Baltimore, and Toronto. Telephone interviews were conducted with 228 patients and 301 control subjects who were reached by random-digit dialing.
Results: Fifty-eight percent of the patients and 24 percent of the control subjects were current smokers. Invasive pneumococcal disease was associated with cigarette smoking (odds ratio, 4.1; 95 percent confidence interval, 2.4 to 7.3) and with passive smoking among nonsmokers (odds ratio, 2.5; 95 percent confidence interval, 1.2 to 5.1) after adjustment by logistic-regression analysis for age, study site, and independent risk factors such as male sex, black race, chronic illness, low level of education, and living with young children who were in day care. There were dose-response relations for the current number of cigarettes smoked per day, pack-years of smoking, and time since quitting. The adjusted population attributable risk was 51 percent for cigarette smoking, 17 percent for passive smoking, and 14 percent for chronic illness.
Conclusions: Cigarette smoking is the strongest independent risk factor for invasive pneumococcal disease among immunocompetent, nonelderly adults. Because of the high prevalence of smoking and the large population attributable risk, programs to reduce both smoking and exposure to environmental tobacco smoke have the potential to reduce the incidence of pneumococcal disease.
Comment in
- Smoking and pneumococcal infection.
Sheffield JV, Root RK. Sheffield JV, et al. N Engl J Med. 2000 Mar 9;342(10):732-4. doi: 10.1056/NEJM200003093421010. N Engl J Med. 2000. PMID: 10706905 No abstract available.
Similar articles
- Passive cigarette smoke exposure and other risk factors for invasive pneumococcal disease in children: a case-control study.
Chun CS, Weinmann S, Riedlinger K, Mullooly JP. Chun CS, et al. Perm J. 2015 Winter;19(1):38-43. doi: 10.7812/TPP/14-010. Epub 2014 Nov 24. Perm J. 2015. PMID: 25431997 Free PMC article. - Risk factors for invasive disease among children in Spain.
Pereiró I, Díez-Domingo J, Segarra L, Ballester A, Albert A, Morant A. Pereiró I, et al. J Infect. 2004 May;48(4):320-9. doi: 10.1016/j.jinf.2003.10.015. J Infect. 2004. PMID: 15066333 - The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.
Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA, Deaver KA, Breiman RF. Hofmann J, et al. N Engl J Med. 1995 Aug 24;333(8):481-6. doi: 10.1056/NEJM199508243330803. N Engl J Med. 1995. PMID: 7623880 - Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America.
Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B. Levine OS, et al. Pediatrics. 1999 Mar;103(3):E28. doi: 10.1542/peds.103.3.e28. Pediatrics. 1999. PMID: 10049984 - Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence.
Curcio D, Cané A, Isturiz R. Curcio D, et al. Int J Infect Dis. 2015 Aug;37:30-5. doi: 10.1016/j.ijid.2015.05.003. Epub 2015 May 19. Int J Infect Dis. 2015. PMID: 25997673 Review.
Cited by
- Nasopharyngeal pneumococcal carriage rates among HIV-infected adults following widespread pediatric use of conjugate pneumococcal vaccine-13.
Feola TD, Bonville CA, Cibula DA, Jose S, Nattanmai G, Domachowske JB, Suryadevara M. Feola TD, et al. Hum Vaccin Immunother. 2016 Sep;12(9):2441-6. doi: 10.1080/21645515.2016.1172758. Epub 2016 May 24. Hum Vaccin Immunother. 2016. PMID: 27215541 Free PMC article. - Resistance of Streptococcus pneumoniae to Hypothiocyanous Acid Generated by Host Peroxidases.
Shearer HL, Kaldor CD, Hua H, Kettle AJ, Parker HA, Hampton MB. Shearer HL, et al. Infect Immun. 2022 Mar 17;90(3):e0053021. doi: 10.1128/IAI.00530-21. Epub 2022 Jan 18. Infect Immun. 2022. PMID: 35156851 Free PMC article. - Pneumococcal disease in the elderly: what is preventing vaccine efficacy?
Rubins JB, Janoff EN. Rubins JB, et al. Drugs Aging. 2001;18(5):305-11. doi: 10.2165/00002512-200118050-00001. Drugs Aging. 2001. PMID: 11392439 Review. - Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.
Corsini B, Díez-Martínez R, Aguinagalde L, González-Camacho F, García-Fernández E, Letrado P, García P, Yuste J. Corsini B, et al. Antimicrob Agents Chemother. 2018 May 25;62(6):e02212-17. doi: 10.1128/AAC.02212-17. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29581113 Free PMC article. - A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older.
Steens A, Vestrheim DF, Aaberge IS, Wiklund BS, Storsaeter J, Riise Bergsaker MA, Rønning K, Furuseth E. Steens A, et al. Epidemiol Infect. 2014 Dec;142(12):2471-82. doi: 10.1017/S0950268814001514. Epub 2014 Jun 16. Epidemiol Infect. 2014. PMID: 24932959 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical